NCT00469001已完成不适用
Phase 1 Study of Using BNP as Guided Parameter in Treatment HF
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 108
- 试验地点
- 1
研究概览
简要总结
To use continuous measurement of NT Pro BNP level as guide in therapy patients with CHF.
详细描述
Group of 100 patients with CHF, NYHA II-IY will be followed for 1 years in outpatient clinic of our hospital for hospitalization, death, 6 min walking protocol, number of decompensation as a primary end point. 50 patients will be treated according usual practice in outpatient clinics and in 50 patients will be additionally used level of NT Pro BNP as additional parameter.If level NT Pro BNP will be goes down will not be changes in treatment regiment. If level of NT Pro BNP will be increased treatment will be intensified.At the end of 1 year follow up we will compare the result of two strategies.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient older 18 y.old with CHF NYHA II-IY.
排除标准
- •All conditions with life expectancy less than 2 years.
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Prospective Evaluation of the StatusFirst™ CHF NT-proBNP Device in Human Whole Blood and Plasma SamplesCongestive Heart Failure (CHF)NCT00734045Nanogen, Inc.450
已完成
不适用
Using NT-proBNP to Detect Chronic Heart Failure in Patients With Chronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary DiseaseChronic Heart FailureNCT01801722Lund University75
已完成
4 期
Evaluation of Heart Failure Treatment Guided by N-terminal Pro B-type Natriuretic Peptide (NTproBNP) vs Clinical Symptoms and Signs AloneVentricular Dysfunction, LeftHeart FailureNCT00391846AstraZeneca252
已完成
不适用
Point Of Care With Serial NT-proBNP Measurement in Patients With Acute Decompensation of Heart FailureAcute Decompensated Heart FailureNCT04471610Prof. Dr. Jörg Leuppi52
终止
4 期
Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)Heart FailureNCT00206856Abbott RDx Cardiometabolic720
